Publications

Export 5 results:
Auteur Title Type [ Année(Desc)]
Filtres: Auteur is Rabinovici, Gil D  [Enlever les filtres]
2015
Villeneuve S, Rabinovici GD, Cohn-Sheehy BI, Madison C, Ayakta N, Ghosh PM, La Joie R, Arthur-Bentil SKate, Vogel JW, Marks SM et al..  2015.  Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation.. Brain. 138(Pt 7):2020-33.
2016
Laforce R, Rosa-Neto P, Soucy J-P, Rabinovici GD, Dubois B, Gauthier S.  2016.  Canadian Consensus Guidelines on Use of Amyloid Imaging in Canada: Update and Future Directions from the Specialized Task Force on Amyloid imaging in Canada.. Can J Neurol Sci. 43(4):503-12.
Dubois B, Hampel H, Feldman HH, Scheltens P, Aisen P, Andrieu S, Bakardjian H, Benali H, Bertram L, Blennow K et al..  2016.  Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.. Alzheimers Dement. 12(3):292-323.
2017
Seo SWon, Ayakta N, Grinberg LT, Villeneuve S, Lehmann M, Reed B, DeCarli C, Miller BL, Rosen HJ, Boxer AL et al..  2017.  Regional correlations between [(11)C]PIB PET and post-mortem burden of amyloid-beta pathology in a diverse neuropathological cohort.. Neuroimage Clin. 13:130-137.
2020
[Anonymous].  2020.  The impact of demographic, clinical, genetic, and imaging variables on tau PET status.. Eur J Nucl Med Mol Imaging.